It is with great excitement that we unveil our network-wide redesign. Please read further to learn more about a few of our new features, and browse around to explore the new site!
Patients with heart failure and reduced ejection fraction (HF-REF) treated with an investigational angiotensin receptor neprilysin Inhibitor (ARNI) are more likely to reduce cardiovascular death and heart failure hospitalization than...
Teens who received the collaborative care intervention in primary care had significantly greater improvements in depressive symptoms than teens who were receiving treatment as usual.

LATEST
FDA: Keep boxed warning on Chantix

An FDA advisory committee has voted to keep the boxed warning for varenicline (Chantix, Pfizer) that states that the drug ...

[BLOG]: Providers and payers share ...
Unprecedented efficacy of latest ...
Public-private partnerships in ...
Positive results found for ...

FDA APPROVALS
FDA approves abuse-deterrent ...

FDA has approved an updated labeling of morphine sulfate/naltrexone hydrochloride (Embeda, Pfizer) extended release ...

FDA approves antiemetic agent for ...
FDA approves bortezomib for ...
FDA’s new hep C approval: A step ...

CLINICAL
FDA: Keep boxed warning on Chantix

An FDA advisory committee has voted to keep the boxed warning for varenicline (Chantix, Pfizer) that states that the drug ...

FDA approves abuse-deterrent ...
[BLOG]: Providers and payers share ...
Unprecedented efficacy of latest ...

DRUGS IN PERSPECTIVE
Drug Overview: Zykadia (ceritinib)

Zykadia (ceritinib) is a tyrosine kinase inhibitor that was approved by FDA on April 29, 2014, as a medication for the ...

Drugs in Perspective: Dalvance
Drug Overview: Tasimelteon (Hetlioz)
Drug Overview: Aptiom ...

Latest Tweets Follow